Abbott seeks to end buyout deal for Alere

Abbott Laboratories agreed to buy Alere Inc. in February for $56 per share, or $5.8 billion, in a move to expand its medical device offerings.

[...] Alere, based in Waltham, Massachusetts, has recalled a key monitoring device, delayed a key financial statement, and is being investigated over its overseas businesses.